Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Sanchez-Felix, Manuel
4301  Ergebnisse:
Personensuche X
?
1

Pharmaceutical and biotech industry perspectives on optimiz..:

Stevenson, Jennifer ; Poker, Rachel ; Schoss, Johanna...
Advanced Drug Delivery Reviews.  209 (2024)  - p. 115322 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Protein Based Amorphous Solid Dispersion: a Case Study Inve..:

Leng, Donglei ; Bulduk, Bulut ; Widmer, Toni...
Pharmaceutical Research.  40 (2023)  7 - p. 1865-1872 , 2023
Link: https://doi.org/10.1007/..
 
?
3

Drug delivery breakthrough technologies – A perspective on ..:

Bittner, Beate ; Sánchez-Félix, Manuel ; Lee, Dennis...
Journal of Controlled Release.  360 (2023)  - p. 335-343 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Accelerating the development of novel technologies and tool..:

Collins, David S. ; Sánchez-Félix, Manuel ; Badkar, Advait V..
Journal of Controlled Release.  321 (2020)  - p. 475-482 , 2020
Link: https://doi.org/10.1016/..
 
?
5

The Evolving Druggability and Developability Space: Chemica..:

Yang, Wenzhan ; Gadgil, Prajakta ; Krishnamurthy, Venkata R....
The AAPS Journal.  22 (2020)  2 - p. , 2020
Link: https://doi.org/10.1208/..
 
?
6

Predicting bioavailability of monoclonal antibodies after s..:

Sánchez-Félix, Manuel ; Burke, Matt ; Chen, Hunter H...
Advanced Drug Delivery Reviews.  167 (2020)  - p. 66-77 , 2020
Link: https://doi.org/10.1016/..
 
?
7

Prediction of ARA/PPI Drug-Drug Interactions at the Drug Di..:

Dodd, Stephanie ; Kollipara, Sivacharan ; Sanchez-Felix, Manuel...
Journal of Pharmaceutical Sciences.  108 (2019)  1 - p. 87-101 , 2019
Link: https://doi.org/10.1016/..
 
?
8

Activity of nitazoxanide and tizoxanide against Mycobacteri..:

Harausz, Elizabeth P. ; Chervenak, Keith A. ; Good, Caryn E....
Tuberculosis.  98 (2016)  - p. 92-96 , 2016
Link: https://doi.org/10.1016/..
 
?
9

Summary Workshop Report: Facilitating Oral Product Developm..:

Polli, James E. ; Cook, Jack A. ; Davit, Barbara M....
The AAPS Journal.  14 (2012)  3 - p. 627-638 , 2012
Link: https://doi.org/10.1208/..
 
?
10

Erratum to: Discovery of LY2457546: a multi-targeted anti-a..:

Burkholder, Timothy P. ; Clayton, Joshua R. ; Rempala, Mark E....
Investigational New Drugs.  30 (2011)  3 - p. 1270-1271 , 2011
Link: https://doi.org/10.1007/..
 
?
11

Discovery of LY2457546: a multi-targeted anti-angiogenic ki..:

Burkholder, Timothy P. ; Clayton, Joshua R. ; Rempala, Mark E....
Investigational New Drugs.  30 (2011)  3 - p. 936-949 , 2011
Link: https://doi.org/10.1007/..
 
?
12

List of contributors:

, In: Oral Delivery of Therapeutic Peptides and Proteins,
Arora, Meenakshi ; Bak, Annette ; Davies, Nigel M.... - p. xi-xii , 2022
Link: https://doi.org/10.1016/..
 
?
13

A biopharmaceutics perspective on oral peptide developabili..:

, In: Oral Delivery of Therapeutic Peptides and Proteins,
Ganesh, Ahil N. ; Garad, Sudhakar ; Sanchez-Felix, Manuel V. - p. 87-130 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Patient-centric design for peptide delivery: Trends in rout..:

Ganesh, Ahil N. ; Heusser, Carolyn ; Garad, Sudhakar.
Medicine in Drug Discovery.  9 (2021)  - p. 100079 , 2021
Link: https://doi.org/10.1016/..
 
?
15

Amorphous Solid Dispersions (ASDs): The Influence of Materi..:

Iyer, Raman ; Petrovska Jovanovska, Vesna ; Berginc, Katja...
Pharmaceutics.  13 (2021)  10 - p. 1682 , 2021
Link: https://doi.org/10.3390/..
 
1-15